| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.04. | Red Light Holland Corp.: Red Light Holland Reports Continued Expansion of Filament Health's PEX010 Clinical Network with New License Agreements and Research Shipments | 447 | Newsfile | Three new license agreements signed and two research shipments completed in March 2026, spanning institutions in Australia, the United Kingdom, and CanadaToronto, Ontario--(Newsfile Corp. - April... ► Artikel lesen | |
| 01.04. | Red Light Holland Corp.: Red Light Holland to Support University of California San Francisco's Global Psychedelic Study Through Filament Health's Clinical Network | 509 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") today announced that, through Filament Health Corp.... ► Artikel lesen | |
| 23.03. | Red Light Holland Corp.: Red Light Holland Announces Filament Health Obtains Interim Order for Proposed Arrangement | 322 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 23, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Filament Health Corp. (OTC: FLHLF) ("Filament")... ► Artikel lesen | |
| 18.03. | Red Light Holland Corp.: Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate | 612 | Newsfile | AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio's purpose-built agentic AI platform for the biotechnology industryToronto... ► Artikel lesen | |
| 16.03. | Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression | 941 | ACCESS Newswire | Whole leaf coca extract under evaluation is Magdalena's drug candidate for post-GLP-1 weight loss management SAN FRANCISCO, CA / ACCESS Newswire / March 16, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX)... ► Artikel lesen | |
| FILAMENT HEALTH Aktie jetzt für 0€ handeln | |||||
| 10.03. | Red Light Holland Corp.: Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation | 564 | Newsfile | Expands Red Light's drug development platform with Filament's GMP manufacturing, Health Canada Dealer's Licence, Health Canada and FDA-authorized clinical programs, and 76 issued patents covering... ► Artikel lesen | |
| 07.11.25 | Filament Health Announces Third Quarter 2025 Financial Results And Operational Highlights | 5 | CNW | ||
| 08.07.25 | Jaguar Health, Inc.: Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health | 647 | ACCESS Newswire | Magdalena is focused on developing novel, natural prescription medicines derived from plants for mental health indications SAN FRANCISCO, CA / ACCESS Newswire / July 8, 2025 /
Jaguar Health, Inc.
(NASDAQ:JAGX)
... ► Artikel lesen | |
| 22.05.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.05.2025 | 923 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 22.05.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.05.2025.ISIN NameCA31685W1068 FILAMENT... ► Artikel lesen | |
| 22.05.25 | XFRA 7QS: AUSSETZUNG/SUSPENSION | 329 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILFILAMENT HEALTH... ► Artikel lesen | |
| 19.05.25 | Filament Health Corp.: Filament Health Announces Voluntary Delisting From Cboe Canada | 285 | PR Newswire | VANCOUVER, BC, May 19, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen | |
| 09.05.25 | Filament Health Corp.: Filament Health Announces First Quarter 2025 Financial Results And Operational Highlights | 205 | PR Newswire | VANCOUVER, BC, May 8, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 40,800 | +0,15 % | Bayer Aktie auf der Kippe: Neuer Kurssturz droht, aber... | Aktuell verliert die Bayer Aktie in der Vorbörse nur leicht, obwohl sich der "Waffenstillstand" im Iran-Krieg als extrem fragil entpuppt. Ob die Hoffnungen der Anleger auf ein Ende der militärischen... ► Artikel lesen | |
| AURORA CANNABIS | 3,112 | -0,89 % | Nach den Tilray-Zahlen: Aurora, Canopy & Co. vor richtungsweisender Berichtssaison | In einer Phase, in der sich das Handelsgeschehen auf die Auswirkungen des Iran-Krieges zu konzentrieren scheint, nimmt die Quartalsberichtssaison Fahrt auf. Für die Cannabis-Unternehmen wird es möglicherweise... ► Artikel lesen | |
| CANOPY GROWTH | 0,970 | -0,94 % | CANOPY GROWTH CORPORATION: Stabilität als Signal | ||
| TILRAY BRANDS | 5,930 | +0,51 % | Brewdog can be worth $1bn, new owner says | ||
| INNOCAN PHARMA | 4,090 | +2,76 % | InnoCan Pharma mit Rekordsignal: Was große Adressen heute bereits wissen - So reagieren erfahrene Anleger jetzt | ||
| CRONOS GROUP | 2,270 | -1,73 % | Cronos Group Inc.: Cronos Group Reports 2025 Fourth Quarter and Full-Year Results | Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025... ► Artikel lesen | |
| SYNBIOTIC | 1,722 | -2,71 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr 2026 | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Prognose
SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,020 | +0,67 % | Green Thumb Industries Inc: Green Thumb releases social impact report | ||
| CHRISTINA LAKE CANNABIS | 0,019 | 0,00 % | Christina Lake Cannabis Corp: Christina Lake investor Milia acquires 5.03M shares | ||
| AXSOME THERAPEUTICS | 156,35 | +0,51 % | UBS raises Axsome Therapeutics price target on Auvelity outlook | ||
| JAZZ PHARMACEUTICALS | 169,65 | +0,41 % | Prognose massiv erhöht - Wird der australische Psychodelika-Spezialist Bioxyne zum neuen Branchenliebling? | ||
| JAGUAR HEALTH | 0,419 | 0,00 % | Jaguar Health, Inc.: Artificial Intelligence Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure Programs | Global Market for Short Bowel Syndrome, Including Intestinal Failure (IF), Estimated to Reach $8.0 Billion by 20331AI data mining of real world clinical and symptom manifestation is beneficial in the... ► Artikel lesen | |
| TRULIEVE CANNABIS | 5,520 | -2,30 % | Trulieve Cannabis Corp: Trulieve Cannabis to open Boca Raton shop on April 24 | ||
| CORBUS PHARMACEUTICALS | 8,315 | -2,06 % | Corbus completes enrollment in obesity drug trial | ||
| AVALO THERAPEUTICS | 11,300 | -0,18 % | Avalo Therapeutics Reports 2025 Financial Results and Recent Business Updates | Topline data expected from Phase 2 LOTUS trial of abdakibart (AVTX-009) for the treatment of hidradenitis suppurativa in the second quarter of 2026Cash, cash equivalents and short-term investments... ► Artikel lesen |